Listed

Larimar Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Mar 9, 2018 and accepted by EDGAR at Mar 9, 2018, 16:44 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-10-01 to 2017-12-31$0us-gaap:Revenues
Revenue12 months2017-01-01 to 2017-12-31$0us-gaap:Revenues
Research and development12 months2017-01-01 to 2017-12-31$40.8mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2017-01-01 to 2017-12-31−$53.0mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$165.0kus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-10-01 to 2017-12-31−$13.1mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income12 months2017-01-01 to 2017-12-31−$52.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-10-01 to 2017-12-31−$0.48us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2017-01-01 to 2017-12-31−$1.90us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure12 months2017-01-01 to 2017-12-31$55.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-12-31$40.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$104.9mus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$105.5mus-gaap:Assets
Current liabilitiesAt period end2017-12-31$7.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$27.3mus-gaap:Liabilities
Long-term debtAt period end2017-12-31$20.0mus-gaap:LongTermDebt
Shareholders' equityAt period end2017-12-31$78.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-18-077456. Last ingested by Listed: Nov 13, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.